These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32872677)

  • 21. Phosphodiesterase-4 inhibition augments human lung fibroblast vascular endothelial growth factor production induced by prostaglandin E2.
    Ikari J; Michalski JM; Iwasawa S; Gunji Y; Nogel S; Park JH; Nelson AJ; Farid M; Wang X; Schulte N; Basma H; Toews ML; Feghali-Bostwick C; Tenor H; Liu X; Rennard SI
    Am J Respir Cell Mol Biol; 2013 Oct; 49(4):571-81. PubMed ID: 23656623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease.
    Rabe KF
    Br J Pharmacol; 2011 May; 163(1):53-67. PubMed ID: 21232047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production of highly bioactive resveratrol analogues pterostilbene and piceatannol in metabolically engineered grapevine cell cultures.
    Martínez-Márquez A; Morante-Carriel JA; Ramírez-Estrada K; Cusidó RM; Palazon J; Bru-Martínez R
    Plant Biotechnol J; 2016 Sep; 14(9):1813-25. PubMed ID: 26947765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brief Communication: SIR-2.1-dependent lifespan extension of Caenorhabditis elegans by oxyresveratrol and resveratrol.
    Lee J; Kwon G; Park J; Kim JK; Lim YH
    Exp Biol Med (Maywood); 2016 Oct; 241(16):1757-63. PubMed ID: 27190265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel assay for replicative lifespan in Saccharomyces cerevisiae.
    Jarolim S; Millen J; Heeren G; Laun P; Goldfarb DS; Breitenbach M
    FEMS Yeast Res; 2004 Nov; 5(2):169-77. PubMed ID: 15489200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The PDE4 inhibitor roflumilast improves memory in rodents at non-emetic doses.
    Vanmierlo T; Creemers P; Akkerman S; van Duinen M; Sambeth A; De Vry J; Uz T; Blokland A; Prickaerts J
    Behav Brain Res; 2016 Apr; 303():26-33. PubMed ID: 26794595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GSK256066, an exceptionally high-affinity and selective inhibitor of phosphodiesterase 4 suitable for administration by inhalation: in vitro, kinetic, and in vivo characterization.
    Tralau-Stewart CJ; Williamson RA; Nials AT; Gascoigne M; Dawson J; Hart GJ; Angell AD; Solanke YE; Lucas FS; Wiseman J; Ward P; Ranshaw LE; Knowles RG
    J Pharmacol Exp Ther; 2011 Apr; 337(1):145-54. PubMed ID: 21205923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cells.
    Growcott EJ; Spink KG; Ren X; Afzal S; Banner KH; Wharton J
    Respir Res; 2006 Jan; 7(1):9. PubMed ID: 16423283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan.
    Howitz KT; Bitterman KJ; Cohen HY; Lamming DW; Lavu S; Wood JG; Zipkin RE; Chung P; Kisielewski A; Zhang LL; Scherer B; Sinclair DA
    Nature; 2003 Sep; 425(6954):191-6. PubMed ID: 12939617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of mitochondrial function correlates with the extension of lifespan by caloric restriction and caloric restriction mimetics in yeast.
    Choi KM; Lee HL; Kwon YY; Kang MS; Lee SK; Lee CK
    Biochem Biophys Res Commun; 2013 Nov; 441(1):236-42. PubMed ID: 24141116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficient synthesis of natural polyphenolic stilbenes: resveratrol, piceatannol and oxyresveratrol.
    Sun HY; Xiao CF; Cai YC; Chen Y; Wei W; Liu XK; Lv ZL; Zou Y
    Chem Pharm Bull (Tokyo); 2010 Nov; 58(11):1492-6. PubMed ID: 21048342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PDE4 inhibition reduces neointima formation and inhibits VCAM-1 expression and histone methylation in an Epac-dependent manner.
    Lehrke M; Kahles F; Makowska A; Tilstam PV; Diebold S; Marx J; Stöhr R; Hess K; Endorf EB; Bruemmer D; Marx N; Findeisen HM
    J Mol Cell Cardiol; 2015 Apr; 81():23-33. PubMed ID: 25640159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.
    Chong J; Leung B; Poole P
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD002309. PubMed ID: 28922692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitor.
    Bundschuh DS; Eltze M; Barsig J; Wollin L; Hatzelmann A; Beume R
    J Pharmacol Exp Ther; 2001 Apr; 297(1):280-90. PubMed ID: 11259555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of the chemopreventive agent resveratrol and its metabolite, piceatannol, with model membranes.
    Wesołowska O; Kuzdzał M; Strancar J; Michalak K
    Biochim Biophys Acta; 2009 Sep; 1788(9):1851-60. PubMed ID: 19527681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resveratrol and Lifespan in Model Organisms.
    Pallauf K; Rimbach G; Rupp PM; Chin D; Wolf IM
    Curr Med Chem; 2016; 23(41):4639-4680. PubMed ID: 27781945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct Inhibitory Effect of the PDE4 Inhibitor Roflumilast on Neutrophil Migration in Chronic Obstructive Pulmonary Disease.
    Dunne AE; Kawamatawong T; Fenwick PS; Davies CM; Tullett H; Barnes PJ; Donnelly LE
    Am J Respir Cell Mol Biol; 2019 Apr; 60(4):445-453. PubMed ID: 30395484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population pharmacokinetic modelling of roflumilast and roflumilast N-oxide by total phosphodiesterase-4 inhibitory activity and development of a population pharmacodynamic-adverse event model.
    Lahu G; Hünnemeyer A; Diletti E; Elmlinger M; Ruth P; Zech K; McCracken N; Facius A
    Clin Pharmacokinet; 2010 Sep; 49(9):589-606. PubMed ID: 20690782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Phosphodiesterase-4 Inhibitor Roflumilast, a Potential Treatment for the Comorbidity of Memory Loss and Depression in Alzheimer's Disease: A Preclinical Study in APP/PS1 Transgenic Mice.
    Wang H; Zhang FF; Xu Y; Fu HR; Wang XD; Wang L; Chen W; Xu XY; Gao YF; Zhang JG; Zhang HT
    Int J Neuropsychopharmacol; 2020 Dec; 23(10):700-711. PubMed ID: 32645141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose dependent effects of tadalafil and roflumilast on ovalbumin-induced airway hyperresponsiveness in guinea pigs.
    Urbanova A; Medvedova I; Kertys M; Mikolka P; Kosutova P; Mokra D; Mokrý J
    Exp Lung Res; 2017; 43(9-10):407-416. PubMed ID: 29220595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.